title: Potential savings of consulting a drug information center.
authors.forename: H
authors.initials: H
authors.lastname: Lyrvall
authors.forename: C
authors.initials: C
authors.lastname: Nordin
authors.forename: E
authors.initials: E
authors.lastname: Jonsson
authors.forename: G
authors.initials: G
authors.lastname: Alvan
authors.forename: B
authors.initials: B
authors.lastname: Ohman
mesh_terms: D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000568:Amenorrhea / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001971:Bromocriptine / Q000009:adverse effects; D017046:Cost Savings; D004346:Drug Information Services / Q000191:economics*; D005260:Female; D006801:Humans; D011388:Prolactin / Q000097:blood
chemical_list: D014150:Antipsychotic Agents; D001971:Bromocriptine; D011388:Prolactin